Coffee consumption and mortality after acute myocardial infarction: The Stockholm Heart Epidemiology Program

American Heart Journal

Volumn 157, Issue 3, 2009, Pages 495-501

  Mukamal, Kenneth J ^a   Hallqvist, Johan ^b,c   Hammar, Niklas ^b   Ljung, Rickard ^b,d   Gémes, Katalin ^b,e   Ahlbom, Anders ^b,c   Ahnve, Staffan ^b,c   Janszky, Imre ^b,e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Stockholm Centre of Public Health   (Sweden)

^d CENTRE FOR EPIDEMIOLOGY   (Sweden)

^e SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; COFFEE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROKE; STRUCTURED QUESTIONNAIRE;

AGED; ATRIAL FIBRILLATION; COFFEE; DRINKING; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; STROKE; SWEDEN;

EID: 60649100419     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.11.009     Document Type: Article

References (44)

1. Cornelis M.C., and El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol 18 (2007) 13-19
2. van Dam R.M., and Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294 (2005) 97-104
3. Kawachi I., Colditz G.A., and Stone C.B. Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J 72 (1994) 269-275
4. Greenland S. A meta-analysis of coffee, myocardial infarction, and coronary death. Epidemiology 4 (1993) 366-374
5. Rosner S.A., Akesson A., Stampfer M.J., et al. Coffee consumption and risk of myocardial infarction among older Swedish women. Am J Epidemiol 165 (2007) 288-293
6. Lopez-Garcia E., van Dam R.M., Willett W.C., et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 113 (2006) 2045-2053
7. Andersen L.F., Jacobs Jr. D.R., Carlsen M.H., et al. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 83 (2006) 1039-1046
8. Willett W.C., Stampfer M.J., Manson J.E., et al. Coffee consumption and coronary heart disease in women: a ten-year follow-up. J Am Med Assoc 275 (1996) 458-462
9. Kleemola P., Jousilahti P., Pietinen P., et al. Coffee consumption and the risk of coronary heart disease and death. Arch Intern Med 160 (2000) 3393-3400
10. Klag M.J., Mead L.A., LaCroix A.Z., et al. Coffee intake and coronary heart disease. Ann Epidemiol 4 (1994) 425-433
11. Klatsky A.L., Friedman G.D., and Armstrong M.A. Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk. Am J Epidemiol 132 (1990) 479-488
12. Hammar N., Andersson T., Alfredsson L., et al. Association of boiled and filtered coffee with incidence of first nonfatal myocardial infarction: the SHEEP and the VHEEP study. J Intern Med 253 (2003) 653-659
13. Karatzis E., Papaioannou T.G., Aznaouridis K., et al. Acute effects of caffeine on blood pressure and wave reflections in healthy subjects: should we consider monitoring central blood pressure?. Int J Cardiol 98 (2005) 425-430
14. de Vreede-Swagemakers J.J., Gorgels A.P., Weijenberg M.P., et al. Risk indicators for out-of-hospital cardiac arrest in patients with coronary artery disease. J Clin Epidemiol 52 (1999) 601-607
15. Mukamal K.J., Maclure M., Muller J.E., et al. Caffeinated coffee consumption and mortality after acute myocardial infarction. Am Heart J 147 (2004) 999-1004
16. Silletta M.G., Marfisi R., Levantesi G., et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction: results from the GISSI (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico)-Prevenzione trial. Circulation 116 (2007) 2944-2951
17. Reuterwall C., Hallqvist J., Ahlbom A., et al. Higher relative, but lower absolute risks of myocardial infarction in women than in men: analysis of some major risk factors in the SHEEP study. The SHEEP Study Group. J Intern Med 246 (1999) 161-174
18. Romelsjo A., Branting M., Hallqvist J., et al. Abstention, alcohol use and risk of myocardial infarction in men and women taking account of social support and working conditions: the SHEEP case-control study. Addiction 98 (2003) 1453-1462
19. Linnersjo A., Hammar N., Gustavsson A., et al. Recent time trends in acute myocardial infarction in Stockholm, Sweden. Int J Cardiol 76 (2000) 17-21
20. Wiman B., Andersson T., Hallqvist J., et al. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol 20 (2000) 2019-2023
21. Bennet A.M., Prince J.A., Fei G.Z., et al. Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction. Atherosclerosis 171 (2003) 359-367
22. Hammar N., Alfredsson L., Rosen M., et al. A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden. Int J Epidemiol 30 Suppl 1 (2001) S30-S34
23. Ingelsson E., Arnlov J., Sundstrom J., et al. The validity of a diagnosis of heart failure in a hospital discharge register. Eur J Heart Fail 7 (2005) 787-791
24. Mukamal K.J., Tolstrup J.S., Friberg J., et al. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation 112 (2005) 1736-1742
25. Ellekjaer H., Holmen J., Kruger O., et al. Identification of incident stroke in Norway: hospital discharge data compared with a population-based stroke register. Stroke 30 (1999) 56-60
26. Umemura T., Ueda K., Nishioka K., et al. Effects of acute administration of caffeine on vascular function. Am J Cardiol 98 (2006) 1538-1541
27. Parsons L.S. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference; 2001 (2001), SAS Institute, Inc., Cary (NC) 214-226
28. Bidel S., Hu G., Qiao Q., et al. Coffee consumption and risk of total and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 49 (2006) 2618-2626
29. Greenberg J.A., Dunbar C.C., Schnoll R., et al. Caffeinated beverage intake and the risk of heart disease mortality in the elderly: a prospective analysis. Am J Clin Nutr 85 (2007) 392-398
30. Paganini-Hill A., Kawas C.H., and Corrada M.M. Non-alcoholic beverage and caffeine consumption and mortality: the Leisure World Cohort Study. Prev Med 44 (2007) 305-310
31. Happonen P., Laara E., Hiltunen L., et al. Coffee consumption and mortality in a 14-year follow-up of an elderly northern Finnish population. Br J Nutr (2007) 1-8
32. Svilaas A., Sakhi A.K., Andersen L.F., et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr 134 (2004) 562-567
33. Papamichael C.M., Aznaouridis K.A., Karatzis E.N., et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond) 109 (2005) 55-60
34. Lopez-Garcia E., van Dam R.M., Qi L., et al. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 84 (2006) 888-893
35. Zampelas A., Panagiotakos D.B., Pitsavos C., et al. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 80 (2004) 862-867
36. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
37. Chelsky L.B., Cutler J.E., Griffith K., et al. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA 264 (1990) 2236-2240
38. Graboys T.B., Blatt C.M., and Lown B. The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med 149 (1989) 637-639
39. Hicks J.J., Montes-Cortes D.H., Cruz-Dominguez M.P., et al. Antioxidants decrease reperfusion induced arrhythmias in myocardial infarction with ST-elevation. Front Biosci 12 (2007) 2029-2037
40. Chen W.P., Su M.J., and Hung L.M. In vitro electrophysiological mechanisms for antiarrhythmic efficacy of resveratrol, a red wine antioxidant. Eur J Pharmacol 554 (2007) 196-204
41. Zock P.L., Katan M.B., Merkus M.P., et al. Effect of a lipid-rich fraction from boiled coffee on serum cholesterol. Lancet 335 (1990) 1235-1237
42. Cleophas T.J., Tuinenberg E., van der Meulen J., et al. Wine consumption and other dietary variables in males under 60 before and after acute myocardial infarction. Angiology 47 (1996) 789-796
43. Dorn J., Naughton J., Imamura D., et al. Correlates of compliance in a randomized exercise trial in myocardial infarction patients. Med Sci Sports Exerc 33 (2001) 1081-1089
44. Horwitz R.I., and Horwitz S.M. Adherence to treatment and health outcomes. Arch Intern Med 153 (1993) 1863-1868